Assessment of TMB, PD-L1, and lymphocyte to monocyte ratio as predictive potential in a phase Ib study of sintilimab in patients with advanced solid tumors.
Jiang H, Li N, Wang H, Chen Z, Zheng Y, Qian J, Mao C, Xu X, Xiao C, Zhang X, Zhou H, Wang S, Chen W, Yin X, Sun J, Peng B, Teng L, Xu N.
Jiang H, et al. Among authors: mao c.
Am J Cancer Res. 2021 Sep 15;11(9):4259-4276. eCollection 2021.
Am J Cancer Res. 2021.
PMID: 34659886
Free PMC article.